Clinical Trials Browser

Gliosarcoma × Bortezomib × Clear all

NCT00998010 2020-08-28

Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Phase 2 Completed

24 enrolled 10 charts

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00641706 2014-05-14

Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme

Phase 2 Completed

44 enrolled 9 charts

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT00611325 2014-03-12

Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma

Phase 2 Completed

56 enrolled 11 charts

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

NCT00544284 2013-02-15

Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment

Phase 1 Completed

CNSLymphoidSarcoma

Astrocytoma, Brain Neoplasms, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Lymphoma, Medulloblastoma, Meningioma, Neoplasm Metastasis, Oligodendroglioma, Pinealoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

NCT00006773 2013-01-24

Bortezomib in Treating Patients With Recurrent Glioma

Phase 1 Terminated

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Gliosarcoma